通过选择性抑制酸酶调节子单元来预防蛋白质稳定性疾病
Indrajit Das1, Agnieszka Krzyzosiak1, Kim Schneider1
1Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK.
概括
一个新型小分子Sephin1可以选择性地抑制蛋白酸酶调节子单元. 这种方法可以安全地防止蛋白质错折疾病,如Charcot-Marie-Tooth 1B和老鼠的ALS.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 蛋白质酸化对于细胞功能至关重要.
- 蛋白激酶是已知的药物点,但酸酶具有挑战性.
- 蛋白质酸酶的失调有助于各种疾病.
研究的目的:
- 鉴定和描述蛋白质酸酶1调控子单元的选择性抑制剂.
- 在蛋白质错折疾病中研究抑制压力诱导的酸酶的治疗潜力.
主要方法:
- 开发Sephin1,一种选择性抑制PPP1R15A.A的抑制剂.
- 在体外和体内研究,使用蛋白质错折叠疾病的细胞模型和小鼠模型.
- 在疾病模型中评估运动,形态和分子表型.
主要成果:
- 塞芬1选择性地抑制了压力诱导的PPP1R15A,延长了适应性信号传递.
- Sephin1治疗保护细胞免受蛋白质错折压力.
- 在Charcot-Marie-Tooth 1B和ALS小鼠模型中,Sephin1安全地改善了疾病表型.
结论:
- 蛋白酸酶的调控子单元是可行的药物标.
- 塞芬1证明了对蛋白质错折疾病的治疗潜力.
- 向酸酶为治疗神经退行性疾病提供了一个新的策略.
相关概念视频
Protein Kinases and Phosphatases
15.7K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.7K
Protein Kinases and Phosphatases
4.7K
4.7K
The Proteasome
2.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
2.0K
The Proteasome
10.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.7K
Regulated Protein Degradation
9.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
9.3K
Regulated Protein Degradation
3.4K
3.4K


